1. Introduction

The Decentralized Neurogovernance Doctrine is an emerging legal and regulatory concept concerned with the distribution of authority, responsibility, accountability and decision-making power over neurotechnology, neural data, brain-computer interfaces (BCIs), neuroprosthetics and artificial intelligence systems that process information generated by the human brain.

The doctrine proposes that governance of neurotechnology should not remain exclusively under the control of central governments, technology corporations, hospitals or individual research institutions. Instead, regulatory responsibilities should be distributed among multiple independent institutions, including:

Government regulatory authorities.

Data protection and privacy commissioners.

Medical institutions and research ethics committees.

Independent neurotechnology oversight bodies.

Courts and human rights commissions.

Patients, research participants and affected communities.

Independent technical auditors and cybersecurity authorities.

Its central objective is to protect mental privacy, cognitive liberty, psychological integrity, freedom of thought and human autonomy while allowing responsible scientific and medical innovation.

An important qualification is that Decentralized Neurogovernance is not yet a universally recognised, independent legal doctrine established by a single statute or judicial decision. It is a developing theoretical framework derived from constitutional rights, medical law, data protection, bioethics, administrative law and emerging neurotechnology regulation.

2. Meaning and Conceptual Foundation

Neurogovernance refers to the legal and institutional regulation of technologies that interact with, measure, interpret, influence or modify the human nervous system.

Examples include:

Brain-computer interfaces.

Neural implants.

Neuroimaging technologies.

AI-based emotion recognition.

Neurological monitoring devices.

Cognitive enhancement technologies.

Neuroprosthetic devices.

Neural-data collection platforms.

Digital mental-health monitoring.

Neurostimulation systems.

Decentralized governance distributes regulatory power and responsibility across multiple institutions rather than concentrating it in one authority.

For example, consider a company developing a brain-computer interface that collects neural signals from patients.

Different institutions may exercise different responsibilities:

The medical regulator examines clinical safety.

The data protection authority supervises neural-data processing.

The research ethics committee evaluates informed consent.

An independent cybersecurity auditor examines data security.

Courts provide remedies for violations of constitutional rights.

Patients retain legally protected rights concerning their personal information and bodily autonomy.

This creates a system of shared but clearly allocated regulatory responsibility.

3. Fundamental Principles of the Doctrine

A. Mental Privacy

Mental privacy protects information relating to an individual's cognitive processes, neural activity, emotions and potentially inferred mental states.

Neural information may reveal sensitive characteristics that individuals never intended to disclose.

The doctrine therefore supports:

Restrictions on unauthorised neural-data collection.

Purpose limitation.

Informed consent.

Secure storage and processing.

Restrictions on commercial exploitation.

Protection against unauthorised mental-state inference.

B. Cognitive Liberty

Cognitive liberty concerns an individual's freedom to control their own mental processes.

It includes protection against coercive neurostimulation, involuntary cognitive modification and unjustified interference with mental autonomy.

C. Distributed Accountability

A neurotechnology developer should not escape responsibility merely because another institution operates the device or processes the information.

Responsibility must be allocated according to actual control, knowledge, conduct, statutory duties and contribution to harm.

D. Institutional Independence

Independent oversight is necessary to prevent conflicts of interest where the same institution develops, tests, approves and monitors a neurotechnology product.

E. Informed Consent

Neurotechnology research and clinical treatment should involve meaningful and informed consent.

Consent should explain:

What neural information is collected.

Whether information is used to train AI models.

Who can access the information.

Whether information is transferred internationally.

Whether the device can influence neural activity.

Whether consent can be withdrawn.

What happens to previously collected information.

F. Transparency and Explainability

Where automated systems make decisions based on neural information, individuals should receive meaningful explanations of relevant decisions, subject to applicable law.

4. Institutional Structure of Decentralized Neurogovernance

The doctrine can be implemented through a multi-level governance structure.

A. Government-Level Governance

Governments establish minimum legal standards for neurotechnology research, manufacturing, clinical deployment and commercial applications.

However, decentralization does not mean that governments abandon their supervisory responsibilities.

The state must retain the power to investigate violations, enforce safety standards and protect fundamental rights.

B. Institutional-Level Governance

Hospitals, universities and laboratories should establish independent neurotechnology ethics committees.

These committees should evaluate:

Research involving invasive brain implants.

Human experimentation.

Cognitive enhancement.

Neural-data collection.

Long-term neurological monitoring.

AI-assisted diagnosis.

Potential psychological and neurological harm.

C. Community-Level Governance

Patients and research participants should participate in decisions concerning the collection, storage, use and sharing of their neural information.

This approach is particularly important where neurotechnology is used in educational institutions, workplaces, public-health programmes and disability services.

D. Technological-Level Governance

Technical safeguards should be integrated into neurotechnology platforms.

Examples include encryption, access controls, audit trails, data minimisation, secure deletion and independent security assessments.

Importantly, decentralization should not mean distributing sensitive neural information across uncontrolled blockchain networks or public databases. Governance can be decentralized while personal neural data remains securely stored.

5. Important Case Laws

The following judicial decisions provide the constitutional and legal foundations for the proposed doctrine. Some directly concern brain-related technologies, while others establish broader principles applicable to neurotechnology.

Case 1: Selvi v. State of Karnataka (2010)

Supreme Court of India · (2010) 7 SCC 263

Facts:

The case concerned the involuntary administration of narcoanalysis, polygraph examinations and Brain Electrical Activation Profile (BEAP) tests to persons suspected of criminal offences.

The central question was whether investigative authorities could compel individuals to undergo these scientific techniques.

Judgment:

The Supreme Court held that the involuntary administration of these techniques violated constitutional protections under:

Article 20(3): Protection against compelled self-incrimination.

Article 21: Protection of life and personal liberty.

The Court emphasised personal autonomy, mental privacy and the importance of voluntary participation.

It also addressed the evidentiary limitations associated with these techniques.

Relevance to Decentralized Neurogovernance:

This judgment establishes an important legal foundation against coercive access to mental processes.

It supports the proposition that neurotechnology governance must preserve individual autonomy and prohibit unjustified interference with cognitive freedom.

It is particularly relevant to brain-computer interfaces, neural interrogation and technologies that attempt to extract information from neurological activity.

Source:

Sci API+1

Case 2: Justice K.S. Puttaswamy v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Facts:

The litigation concerned the constitutional validity of the Aadhaar identification framework and whether privacy was protected as a fundamental right under the Indian Constitution.

Judgment:

A nine-judge Constitution Bench unanimously recognised privacy as a fundamental right.

The judgment recognised the relationship between privacy, dignity, liberty, bodily integrity and individual autonomy.

It also recognised informational privacy as an important component of constitutional protection.

The Court established that restrictions on privacy must satisfy legality, legitimate state necessity and proportionality.

Relevance to Decentralized Neurogovernance:

Neural information may reveal highly personal information about an individual's physiological and mental condition.

Under the principles of Puttaswamy, the collection and processing of identifiable neural information can raise serious Article 21 privacy concerns.

The judgment supports:

Protection against unauthorised neural surveillance.

Individual control over personal information.

Restrictions on disproportionate government monitoring.

Constitutional scrutiny of commercial data exploitation.

Protection of mental and bodily autonomy.

This decision provides a particularly significant constitutional foundation for developing neurotechnology governance in India.

Source:

Indian Kanoon+1

Case 3: Girardi v. Emotiv Inc. (2023)

Supreme Court of Chile · Rol No. 105.065-2023 · 9 August 2023

Facts:

Guido Girardi used an Emotiv Insight neurotechnology headset capable of recording electrical brain activity.

The dispute concerned the collection, storage and processing of information obtained through the device.

The petitioner raised concerns about the protection of brain data and the risks associated with its commercial use.

Judgment:

The Chilean Supreme Court accepted the constitutional protection claim.

It directed the deletion of information stored in connection with the claimant's device use and required relevant public authorities to examine the device's commercialisation, use and handling of collected data in accordance with national law.

The decision considered privacy, physical and psychological integrity, informed consent and the regulatory oversight of neurotechnology.

Relevance to Decentralized Neurogovernance:

This is one of the most directly relevant judicial decisions for the proposed doctrine.

It demonstrates that neurotechnology governance cannot be left entirely to private technology companies.

Independent regulatory supervision is necessary even when a product is commercially available.

The decision also supports the need for coordination between:

Data protection authorities.

Medical regulators.

Consumer protection institutions.

Technology companies.

Judicial authorities.

Source:

CORTE SUPREMA DE CHILE+2

Case 4: Common Cause v. Union of India (2018)

Supreme Court of India · (2018) 5 SCC 1

Facts:

The case concerned passive euthanasia, advance medical directives and the right to die with dignity.

Judgment:

The Supreme Court recognised the importance of individual autonomy and dignity in end-of-life medical decisions.

It laid down safeguards concerning advance directives and withdrawal of life-sustaining treatment.

Relevance to Decentralized Neurogovernance:

Neurotechnology may involve decisions about brain implants, neurological interventions, treatment withdrawal and long-term life-support systems.

The case provides principles supporting patient autonomy, informed decision-making and dignity in medical treatment.

These principles are relevant when allocating decision-making authority among patients, doctors, hospitals and regulatory institutions.

Case 5: Anuradha Bhasin v. Union of India (2020)

Supreme Court of India · (2020) 3 SCC 637

Facts:

The litigation challenged restrictions on internet access in Jammu and Kashmir.

Judgment:

The Supreme Court examined restrictions on freedom of expression and the use of the internet, emphasising proportionality, transparency and periodic review of restrictive orders.

Relevance to Decentralized Neurogovernance:

Although not a neurotechnology case, its principles are useful where governments restrict access to neurotechnology platforms, impose neurological monitoring requirements or introduce automated systems affecting fundamental rights.

It supports judicial oversight and procedural accountability for governmental decisions.

Case 6: Carpenter v. United States (2018)

Supreme Court of the United States · 585 U.S. 296 (2018)

Facts:

The case involved government access to historical cell-site location information held by mobile service providers.

Judgment:

The US Supreme Court held that accessing the extensive historical location records in question generally constituted a Fourth Amendment search requiring a warrant supported by probable cause.

Relevance to Decentralized Neurogovernance:

The judgment illustrates how technological data held by private companies can generate serious constitutional privacy concerns when accessed by government authorities.

By analogy, government access to neural datasets held by commercial neurotechnology companies should be subject to appropriate legal safeguards.

This is an analogy, not a judicial ruling specifically about brain data.

6. International Legal and Regulatory Framework

A. OECD Recommendation on Responsible Innovation in Neurotechnology (2019)

The OECD adopted its Recommendation on Responsible Innovation in Neurotechnology on 11 December 2019.

It provides an international policy framework for responsible neurotechnology development.

Its nine principles address:

Responsible innovation.

Safety assessment.

Inclusivity.

Scientific collaboration.

Societal deliberation.

Institutional oversight.

Protection of personal brain data.

Responsible stewardship.

Prevention of unintended use and misuse.

The Recommendation expressly recognises cognitive liberty and personal brain data.

It also encourages cooperation across government and private-sector institutions.

This framework closely supports decentralized neurogovernance.

OECD Legal Instruments

B. UNESCO Recommendation on the Ethics of Neurotechnology (2025)

UNESCO adopted the Recommendation on the Ethics of Neurotechnology at its 43rd General Conference in November 2025.

It provides an international normative framework addressing human dignity, mental privacy, autonomy and the ethical development and use of neurotechnology.

Its significance lies in recognising that neurotechnology creates regulatory challenges extending beyond traditional medical applications.

It provides a basis for international cooperation and national institutional safeguards.

UNESCO+2

C. European Data Protection Framework

The General Data Protection Regulation (GDPR) may apply to identifiable neural information.

Depending on its nature and processing, neural data may constitute personal data and may qualify as special-category data, particularly where it reveals health information or other protected characteristics.

The framework provides safeguards concerning:

Lawfulness of processing.

Transparency.

Purpose limitation.

Data minimisation.

Security.

Data subject rights.

Restrictions on certain automated decisions.

It can therefore contribute to a decentralized model in which independent data protection authorities supervise different neurotechnology operators.

7. Application of the Doctrine Under Indian Law

India does not currently have a separate comprehensive Neurotechnology Act. Nevertheless, several existing legal frameworks can provide protection.

A. Constitution of India

Article 21 is particularly important because the human mind and body are central to personal liberty and dignity.

B. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 provides a statutory framework for processing digital personal data.

Its relevance to neurotechnology includes:

Processing identifiable neural information.

Consent and lawful processing.

Obligations of data fiduciaries.

Data security safeguards.

Rights of data principals.

Regulatory supervision and penalties.

However, the Act does not establish a separate statutory category called neural data or create a complete neurorights framework.

Its application will depend on whether the information falls within its definition of digital personal data and the applicable provisions and exemptions.

Official legislation: India Code – Digital Personal Data Protection Act, 2023.

C. Medical and Research Regulation

Neurotechnology involving clinical research and medical devices may also engage:

Drugs and Cosmetics Act, 1940.

Medical Devices Rules, 2017.

New Drugs and Clinical Trials Rules, 2019, where applicable.

Indian Council of Medical Research ethical guidelines.

Biomedical research ethics committee requirements.

These frameworks provide different forms of oversight over medical safety, research participation and clinical experimentation.

8. Liability Under Decentralized Neurogovernance

One of the most important questions is determining who becomes legally responsible when a decentralized neurotechnology system causes harm.

Consider a hypothetical situation:

A hospital uses an AI-powered brain-monitoring device developed by a private company. The device collects neural signals, processes them through cloud infrastructure and produces a neurological risk assessment.

An unauthorised third party obtains the neural information and uses it to discriminate against the patient.

Potential liability may arise at several levels.

The doctrine supports the following principle:

Decentralized institutional authority must not produce decentralized irresponsibility.

Every institution must have clearly defined duties, reporting obligations and accountability mechanisms.

Liability should be determined under the applicable statutory, constitutional, contractual and tort principles rather than automatically imposed on every participant.

9. Major Legal Challenges

A. Fragmentation of Regulatory Authority

Multiple institutions may exercise overlapping regulatory powers.

For example, a medical regulator may examine device safety while a data protection authority investigates unlawful processing.

Without coordination, regulatory gaps and contradictory decisions may arise.

Legal solution: Establish inter-agency cooperation mechanisms and clearly defined statutory responsibilities.

B. Neural-Data Ownership

An important unresolved question is whether neural information should be treated as property, personal data, a component of bodily autonomy or a combination of legally protected interests.

The doctrine favours strong individual rights and control over permissible uses rather than assuming that ownership of a physical device automatically grants ownership of the user's neural information.

C. Cross-Border Neural-Data Transfers

Neurotechnology companies may store neural information in foreign cloud infrastructure.

This creates questions concerning jurisdiction, applicable privacy laws, regulatory cooperation and international enforcement.

Legal solution: Adopt appropriate transfer safeguards, contractual protections and international regulatory cooperation.

D. Algorithmic Discrimination

AI systems may use neurological information to infer attention, emotional states, cognitive performance or behavioural characteristics.

Such inferences may create discrimination in employment, insurance, education and healthcare.

Legal solution: Require appropriate impact assessments, independent audits, transparency and safeguards against unjustified automated decision-making.

E. Cybersecurity Risks

Neural implants and connected brain-computer interfaces may create new security vulnerabilities.

Potential risks include unauthorised access, manipulation of device settings, disclosure of neural information and interference with connected medical systems.

Legal solution: Mandatory security testing, encryption, access restrictions, incident reporting and continuous monitoring.

F. Lack of Specialised Judicial Expertise

Courts may struggle to evaluate complex neurological evidence and AI-generated interpretations.

Legal solution: Develop specialised technical advisory mechanisms, independent scientific experts and appropriate judicial training.

10. Proposed Decentralized Neurogovernance Model

A comprehensive legal model could operate through five interconnected levels.

Five-level governance architecture

Level 1 – Constitutional governance

Human dignity, mental privacy, liberty and cognitive autonomy

Level 2 – Independent regulatory governance

Medical regulators, data protection authorities and oversight institutions

Level 3 – Institutional governance

Hospitals, laboratories, universities and ethics committees

Level 4 – Technological governance

AI audits, encryption, cybersecurity and responsible data processing

Level 5 – Individual and community governance

Informed consent, patient participation, complaints and remedies

The five levels should operate through cooperation, information-sharing and independent accountability.

No institution should be able to exercise unlimited authority over neural information or cognitive interventions.

11. Difference Between Centralized and Decentralized Neurogovernance

Decentralization does not eliminate national standards. Rather, it distributes implementation and supervision while maintaining common minimum legal protections.

12. Future Development of the Doctrine

The future development of Decentralized Neurogovernance requires legal reforms in several areas.

1. Neural-data legislation: Specific safeguards for the collection, storage, processing and commercial use of neural information.

2. Cognitive liberty protection: Stronger protection against involuntary neurological interference.

3. Independent neurotechnology regulators: Specialised institutions capable of examining emerging neurotechnology risks.

4. AI accountability: Clear legal responsibility for AI systems that interpret or influence neurological activity.

5. Neurotechnology consent standards: Enhanced consent requirements for invasive and non-invasive brain technologies.

6. International cooperation: Mechanisms for cross-border neural-data protection and regulatory enforcement.

7. Judicial remedies: Effective remedies for violations of mental privacy, neurological integrity and personal autonomy.

8. Public participation: Inclusion of patients, disability organisations, researchers and affected communities in neurotechnology policymaking.

13. Critical Legal Analysis

The Decentralized Neurogovernance Doctrine raises an important constitutional question: who should control technologies capable of accessing and potentially influencing the human mind?

Exclusive governmental control could create risks of state surveillance and coercion. Exclusive corporate control could create risks of commercial exploitation and private monopolisation of sensitive neural information.

Similarly, completely fragmented governance could result in conflicting standards and accountability gaps.

Consequently, a workable framework should combine:

Centralised minimum constitutional and statutory protections.

Decentralised institutional supervision.

Independent technical assessment.

Meaningful individual consent.

Judicial review.

Clear allocation of liability.

The doctrine should also distinguish between medical neurotechnology used for legitimate treatment and non-medical applications used for behavioural prediction, workplace monitoring or commercial profiling.

Different applications require different levels of scrutiny according to their risks and effects on individual rights.

14. Conclusion

The Decentralized Neurogovernance Doctrine represents an emerging approach to regulating technologies that interact with the human brain and nervous system.

Its principal objective is to ensure that neurotechnology does not become an instrument of uncontrolled governmental surveillance, corporate exploitation, involuntary cognitive interference or discriminatory decision-making.

The Indian Supreme Court's decisions in Selvi v. State of Karnataka and Justice K.S. Puttaswamy v. Union of India, together with the Chilean Supreme Court's decision in Girardi v. Emotiv Inc., provide important judicial foundations for developing this framework.

The OECD's 2019 Recommendation and UNESCO's 2025 Recommendation further demonstrate the importance of responsible, rights-based and cooperative neurotechnology governance.

Ultimately, the doctrine seeks to establish a legal balance between technological innovation and human autonomy: the governance of neurotechnology may be distributed among institutions, but the protection of human dignity and mental integrity must remain universal.

15. Important References for Further Legal Research

Primary research sources:

Supreme Court of India – Selvi judgment

Supreme Court of India – Puttaswamy judgment

Girardi v. Emotiv – Chilean Supreme Court case

OECD – Responsible Innovation in Neurotechnology

UNESCO – Recommendation on the Ethics of Neurotechnology

Academic note: The doctrine discussed here is a proposed jurisprudential framework, not an independently settled cause of action. The cited judgments establish related legal principles; they should not be interpreted as having formally recognised the entire doctrine.